ANNA STRUEBY: Open Payments
NPI 1851061568 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 61 payments from 24 companies in 2025. Trend: 2023 $1,046 · 2024 $1,138 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $169 |
| Genentech USA, Inc. | 5 | $96 |
| PFIZER INC. | 4 | $86 |
| Merck Sharp & Dohme LLC | 4 | $83 |
| Janssen Biotech, Inc. | 4 | $69 |
| Exelixis Inc. | 3 | $67 |
| Gilead Sciences, Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $62 |
| GlaxoSmithKline, LLC. | 4 | $60 |
| GENZYME CORPORATION | 3 | $60 |
Products named: KEYTRUDA, CABOMETYX, Trodelvy, SARCLISA, Tecentriq, ENHERTU, RYBREVANT, Orserdu.
Industry payments across MO — which companies pay providers there.
